Arrowpoint Investment Partners’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,273
Closed -$539K 135
2026
Q1
$539K Sell
16,273
-2,929
-15% -$95.2K 0.48% 38
2025
Q4
$628K Buy
+19,202
New +$472K 0.09% 61

Other funds holding AXGN

Arrowpoint Investment Partners's AXGN Position: Q2 2026 in Review

Arrowpoint Investment Partners sold out of Axogen (AXGN) in Q2 2026, closing a stake of 16,273 shares — an estimated $539K sold.

Arrowpoint Investment Partners first reported a position in AXGN in Q4 2025 and held it in 2 quarters. The position peaked at $628K in Q4 2025. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Arrowpoint Investment Partners reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 16,273 Axogen shares in Q2 2026, an estimated $539K.
  • Arrowpoint Investment Partners first reported a position in Axogen in Q4 2025 and held it in 2 quarters.
  • Arrowpoint Investment Partners's Axogen position peaked at $628K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.